SARDU, Celestino
 Distribuzione geografica
Continente #
EU - Europa 10.066
AS - Asia 4.946
NA - Nord America 4.169
SA - Sud America 728
AF - Africa 82
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 1
Totale 20.000
Nazione #
RU - Federazione Russa 6.668
US - Stati Uniti d'America 4.071
SG - Singapore 1.502
IT - Italia 1.317
CN - Cina 893
VN - Vietnam 884
IE - Irlanda 874
HK - Hong Kong 792
BR - Brasile 601
GB - Regno Unito 282
DE - Germania 280
IN - India 256
KR - Corea 250
FR - Francia 129
UA - Ucraina 119
JP - Giappone 97
TR - Turchia 70
FI - Finlandia 66
NL - Olanda 59
GR - Grecia 54
SE - Svezia 45
CA - Canada 44
AR - Argentina 38
BD - Bangladesh 36
MX - Messico 36
AT - Austria 35
EC - Ecuador 23
CZ - Repubblica Ceca 21
DK - Danimarca 21
PK - Pakistan 20
ZA - Sudafrica 20
ID - Indonesia 19
IQ - Iraq 19
PL - Polonia 19
BE - Belgio 17
CO - Colombia 17
IR - Iran 14
ET - Etiopia 13
PY - Paraguay 13
LT - Lituania 12
CL - Cile 11
IL - Israele 10
SA - Arabia Saudita 10
SC - Seychelles 10
EG - Egitto 9
MA - Marocco 9
PE - Perù 9
VE - Venezuela 9
AU - Australia 8
ES - Italia 8
UZ - Uzbekistan 8
KE - Kenya 7
PT - Portogallo 7
TW - Taiwan 7
AZ - Azerbaigian 6
CH - Svizzera 6
JO - Giordania 6
PH - Filippine 6
AE - Emirati Arabi Uniti 5
MY - Malesia 5
TN - Tunisia 5
JM - Giamaica 4
OM - Oman 4
RS - Serbia 4
TH - Thailandia 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
BO - Bolivia 3
DZ - Algeria 3
EE - Estonia 3
GE - Georgia 3
LV - Lettonia 3
NP - Nepal 3
SY - Repubblica araba siriana 3
AL - Albania 2
BB - Barbados 2
CR - Costa Rica 2
CY - Cipro 2
HU - Ungheria 2
KG - Kirghizistan 2
KW - Kuwait 2
KZ - Kazakistan 2
PA - Panama 2
RO - Romania 2
SI - Slovenia 2
SN - Senegal 2
AN - Antille olandesi 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DM - Dominica 1
EU - Europa 1
GD - Grenada 1
HR - Croazia 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LK - Sri Lanka 1
Totale 19.994
Città #
Moscow 2.425
Dublin 865
San Jose 773
Hong Kong 758
Singapore 685
Santa Clara 489
Chandler 304
Ho Chi Minh City 289
Naples 275
Seoul 247
Ashburn 229
Hanoi 217
Jacksonville 217
Hefei 190
Bengaluru 187
Caserta 158
Dallas 147
The Dalles 144
Beijing 136
Princeton 103
New York 100
Roxbury 95
Los Angeles 84
Munich 83
Ann Arbor 75
Medford 70
São Paulo 62
Bremen 58
Da Nang 57
Aversa 50
Wilmington 48
Milan 40
Haiphong 38
Cambridge 36
Amsterdam 35
Woodbridge 34
Istanbul 31
Ercolano 30
Falkenstein 30
Salerno 28
Napoli 27
Orem 26
Des Moines 24
Rome 24
Nuremberg 22
Biên Hòa 21
Chicago 20
Brno 19
Juelsminde 19
Memphis 19
Boardman 18
Nanjing 18
Turku 18
Frankfurt am Main 17
Atlanta 16
Boydton 16
Brussels 16
Council Bluffs 16
Houston 16
Vienna 16
Warsaw 16
Brooklyn 15
Giugliano In Campania 15
Helsinki 15
Hải Dương 15
Sarno 14
Toronto 14
Addis Ababa 13
Chennai 13
Mexico City 13
Montreal 13
Mountain View 13
Rio de Janeiro 13
Tokyo 13
Bari 12
Brasília 12
Hillsboro 12
London 12
Redwood City 12
San Mateo 12
Denver 11
Düsseldorf 11
Lappeenranta 11
Manchester 11
Ninh Bình 11
Shanghai 11
Tianjin 11
Guayaquil 10
Johannesburg 10
Paris 10
Phoenix 10
Porto Alegre 10
Belo Horizonte 9
Castellammare di Stabia 9
Hyderabad 9
Nha Trang 9
San Francisco 9
Vitulazio 9
Vũng Tàu 9
Campinas 8
Totale 10.775
Nome #
Microplastics and Nanoplastics in Atheromas and Cardiovascular Events 332
Abdominal fat SIRT6 expression and its relationship with inflammatory and metabolic pathways in pre-diabetic overweight patients 249
Adiponectin and insulin resistance are related to restenosis and overall new PCI in subjects with normal glucose tolerance: the prospective AIRE Study 221
Autonomic dysfunction is associated with brief episodes of atrial fibrillation in type 2 diabetes. 204
123I-MIBG Scintigraphy in the Subacute State of Takotsubo Cardiomyopathy. 196
Circulating microRNA changes in heart failure patients treated with cardiac resynchronization therapy: responders vs. non-responders 194
Cardiac Hypertrophy: from Pathophysiological Mechanisms to Heart Failure Development 193
Microbiota thrombus colonization may influence athero-thrombosis in hyperglycemic patients with ST segment elevation myocardialinfarction (STEMI). Marianella study 187
Does poor glycaemic control affect the immunogenicity of the COVID-19 vaccination in patients with type 2 diabetes: The CAVEAT study 186
Association between Renal Function at Admission and COVID-19 in-Hospital Mortality in Southern Italy: Findings from the Prospective Multicenter Italian COVOCA Study 183
Sirtuin 6 expression and inflammatory activity in diabetic atherosclerotic plaques: effects of incretin treatment 183
Pericoronary fat inflammation and Major Adverse Cardiac Events (MACE) in prediabetic patients with acute myocardial infarction: Effects of metformin 179
Awaking blood pressure surge and progression to microalbuminuria in type 2 normotensive diabetic patients 177
Cardiac syncope recurrence in type 2 diabetes mellitus patients vs. normoglycemics patients: The CARVAS study 174
Inflammatory cytokines and SIRT1 levels in subcutaneous abdominal fat: Relationship with cardiac performance in overweight pre-diabetics patients 169
MicroRNA-33 and SIRT1 influence the coronary thrombus burden in hyperglycemic STEMI patients 166
An Overview of the Cardiorenal Protective Mechanisms of SGLT2 Inhibitors 166
Sodium/glucose cotransporter 2 (SGLT2) inhibitors improve cardiac function by reducing JunD expression in human diabetic hearts 164
Peri-procedural tight glycemic control during early percutaneous coronary intervention up-regulates endothelial progenitor cell level and differentiation during acute ST-elevation myocardial infarction: effects on myocardial salvage 161
Angiotensin receptor/Neprilysin inhibitor effects in CRTd non-responders: From epigenetic to clinical beside 160
Effects of a Combination of Empagliflozin Plus Metformin vs. Metformin Monotherapy on NAFLD Progression in Type 2 Diabetes: The IMAGIN Pilot Study 159
Molecular mechanisms and therapeutic targets of inflammatory-related Cardiovascular diseases: from molecular mechanisms to therapeutic targets 157
Adiponectin Related Vascular and Cardiac Benefits in Obesity: Is There a Role for an Epigenetically Regulated Mechanism? 156
Left bundle branch pacing and cardiac remodeling in HF patients with type 2 diabetes mellitus: epigenetic pathways and clinical outcomes 155
Dysregulated Epicardial Adipose Tissue as a Risk Factor and Potential Therapeutic Target of Heart Failure with Preserved Ejection Fraction in Diabetes 155
Brief episodes of silent atrial fibrillation predict clinical vascular brain disease in type 2 diabetic patients 154
Aspirin in a Diabetic Retinopathy Setting: insights from NO BLIND Study 154
Glycated ACE2 reduces anti-remodeling effects of renin-angiotensin system inhibition in human diabetic hearts 153
Current Knowledge on the Pathophysiology of Lean/Normal-Weight Type 2 Diabetes 151
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options 151
Atherosclerotic plaque fissuration and clinical outcomes in pre-diabetics vs. normoglycemics patients affected by asymptomatic significant carotid artery stenosis at 2 years of follow-up: Role of micrornas modulation: The atimir study 151
Coronary Microvascular Dysfunction in Diabetes Mellitus: Pathogenetic Mechanisms and Potential Therapeutic Options 151
Effects of incretin treatment on cardiovascular outcomes in diabetic STEMI-patients with culprit obstructive and multivessel non obstructive-coronary-stenosis 150
Glycated ACE2 receptor in diabetes: open door for SARS-COV-2 entry in cardiomyocyte 150
Glycaemic control is associated with SARS-CoV-2 breakthrough infections in vaccinated patients with type 2 diabetes 150
Acute Coronary Occlusion in Patients With Non-ST-Segment Elevation Out-of-Hospital Cardiac Arrest 149
MRI in Pregnancy and Precision Medicine: A Review from Literature 149
SIRT3 mediates the effects of PCSK9 inhibitors on inflammation, autophagy, and oxidative stress in endothelial cells 147
Metformin therapy effects on the expression of sodium-glucose cotransporter 2, leptin, and sirt6 levels in pericoronary fat excised from pre-diabetic patients with acute myocardial infarction 147
Pre-Menopausal Breast Fat Density Might Predict MACE During 10 Years of Follow-Up: The BRECARD Study 146
[HIV and related infections in Italian penal institutions: epidemiological and health organization note] 144
Hyperglycaemia on admission to hospital and COVID-19 141
SGLT2 inhibitor promotes mitochondrial dysfunction and ER-phagy in colorectal cancer cells 141
Lack of effect on in-hospital mortality of drugs used during COVID-19 pandemic: Findings of the retrospective multicenter COVOCA study 140
DNA methylation profiling of CD04+/CD08+ T cells reveals pathogenic mechanisms in increasing hyperglycemia: PIRAMIDE pilot study 140
Long-Term Prognosis among COVID-19 Patients: The Predictive Role Played by Hyperinflammation and Arrhythmic Disorders in Fatal Outcome 139
Metabolic syndrome is associated with a poor outcome in patients affected by outflow tract premature ventricular contractions treated by catheter ablation. 139
Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism. 137
Use of a non-specific immunomodulation therapy as a therapeutic vasculogenesis strategy in no-option critical limb ischemia patients 136
Sodium-glucose co-transporter2 expression and inflammatory activity in diabetic atherosclerotic plaques: Effects of sodium-glucose co-transporter2 inhibitor treatment 136
Infarct size, inflammatory burden, and admission hyperglycemia in diabetic patients with acute myocardial infarction treated with SGLT2-inhibitors: a multicenter international registry 136
Cardiovascular benefits from gliflozins: Effects on endothelial function 134
Could Ghrelin Expression Regulate Diastolic Cardiac Function in Type 2 Diabetic Obese Patients? 133
Impact of Acute Kidney Injury on the COVID-19 In-Hospital Mortality in Octogenarian Patients: Insights from the COVOCA Study 132
Exosomal miR-145 and miR-885 regulate thrombosis in COVID-19 132
Cardiac electrophysiological alterations and clinical response in cardiac resynchronization therapy with a defibrillator treated patients affected by metabolic syndrome 132
Impact of gliflozins on cardiac remodeling in patients with type 2 diabetes mellitus & reduced ejection fraction heart failure: A pilot prospective study. GLISCAR study 131
Non-ST-elevation myocardial infarction outcomes in patients with type 2 diabetes with non-obstructive coronary artery stenosis: Effects of incretin treatment 130
Effects of Sodium-Glucose Transporter 2 Inhibitors (SGLT2-I) in Patients With Ischemic Heart Disease (IHD) Treated by Coronary Artery Bypass Grafting via MiECC: Inflammatory Burden, and Clinical Outcomes at 5 Years of Follow-Up 130
Impact of liver fibrosis on COVID-19 in-hospital mortality in Southern Italy 130
Automated 3D Ultrasound as an Adjunct to Screening Mammography Programs in Dense Breast: Literature Review and Metanalysis 128
Efficacy and durability of multifactorial intervention on mortality and MACEs: a randomized clinical trial in type-2 diabetic kidney disease 128
SGLT-2 inhibitors and in-stent restenosis-related events after acute myocardial infarction: an observational study in patients with type 2 diabetes 128
The number of risk factors not at target is associated with cardiovascular risk in a type 2 diabetic population with albuminuria in primary cardiovascular prevention. Post-hoc analysis of the NID-2 trial 125
Dietary Epigenetic Modulators: Unravelling the Still-Controversial Benefits of miRNAs in Nutrition and Disease 125
Sex-difference of multifactorial intervention on cardiovascular and mortality risk in DKD: post-hoc analysis of a randomised clinical trial 124
Evidence of an anti-inflammatory effect of PCSK9 inhibitors within the human atherosclerotic plaque 124
Advances in the Insulin-Heart Axis: Current Therapies and Future Directions 123
Effects of Alpha Lipoic Acid on Multiple Cytokines and Biomarkers and Recurrence of Atrial Fibrillation Within 1 Year of Catheter Ablation. 123
Pathophysiological mechanisms and clinical evidence of relationship between Nonalcoholic fatty liver disease (NAFLD) and cardiovascular disease 123
GLP-1 receptor agonists-SGLT-2 inhibitors combination therapy and cardiovascular events after acute myocardial infarction: an observational study in patients with type 2 diabetes 123
Author's reply 121
Multipolar pacing by cardiac resynchronization therapy with a defibrillators treatment in type 2 diabetes mellitus failing heart patients: impact on responders rate, and clinical outcomes. 120
Cardiac biomarkers predict 1-year mortality in elderly patients undergoing hip fracture surgery 120
Effects of combination therapy with SGLT2 inhibitors and GLP-1 receptor agonists on CRT response and clinical outcomes in in type 2 diabetes mellitus patients receiving chronic anti-diabetic medications: A multicenter observational study 119
Effects of Metformin in Heart Failure: From Pathophysiological Rationale to Clinical Evidence 118
Cardiac Resynchronization Therapy Outcomes in Type 2 Diabetic Patients: Role of MicroRNA Changes 118
Glycation of ryanodine receptor in circulating lymphocytes predicts the response to cardiac resynchronization therapy 118
Advances in Nanomedicine for Precision Insulin Delivery 117
Functional role of miRNA in cardiac resynchronization therapy. 117
Effects of α-lipoic acid therapy on sympathetic heart innervation in patients with previous experience of transient takotsubo cardiomyopathy 117
Impact of direct acting antivirals (DAAs) on cardiovascular events in HCV cohort with pre-diabetes 117
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: Clinical outcomes at 1-year follow-up 115
Sodium-glucose cotransporter-2 (SGLT2) expression in diabetic and non-diabetic failing human cardiomyocytes 114
The dating of thrombus organization in cases of pulmonary embolism: An autopsy study 114
Impact of chronic liver disease upon admission on COVID-19 in-hospital mortality: Findings from COVOCA study 114
Effects of metformin in heart failure: From pathophysiological rationale to clinical evidence 114
Outcomes in diabetic patients treated with SGLT2-Inhibitors with acute myocardial infarction undergoing PCI: The SGLT2-I AMI PROTECT Registry 113
SARS-COV-2 colonizes coronary thrombus and impairs heart microcirculation bed in asymptomatic SARS-CoV-2 positive subjects with acute myocardial infarction 112
Comparative Outcomes After Percutaneous Coronary Intervention in Unconscious and Conscious Patients With Out-of-Hospital Cardiac Arrest. 111
Cardiovascular Benefits from Gliflozins: Effects on Endothelial Function 111
Calcium release channel RyR2 regulates insulin release and glucose homeostasis 111
Implications of AB0 blood group in hypertensive patients with covid-19 110
Modern Challenges in Type 2 Diabetes: Balancing New Medications with Multifactorial Care 109
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction with and without chronic kidney disease: Insight from SGLT2-I AMI PROTECT registry 109
Effects of SGLT2i therapy on cardiac electrophysiological properties and arrhythmias in diabetic patients with implantable cardiac defibrillator 108
NT-proBNP, IGF-I and survival in patients with chronic heart failure 108
Thrombus aspiration in hyperglycemic ST-elevation myocardial infarction (STEMI) patients: clinical outcomes at 1-year follow-up (vol 17, pg 512, 2018) 108
Effects of metformin therapy on COronary endothelial DYsfunction in prediabetic patients With stable angina and Non Obstructive Coronary Artery Stenosis: The CODYCE Multicenter Prospective Study. 106
SGLT2 breast expression could affect the cardiovascular performance in pre-menopausal women with fatty vs. non fatty breast via over-inflammation and sirtuins' down regulation 104
Totale 14.259
Categoria #
all - tutte 68.791
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.791


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202114 0 0 0 0 0 0 0 0 0 0 0 14
2021/2022841 25 7 44 26 208 14 41 34 44 71 82 245
2022/20231.489 125 53 41 64 182 84 23 70 768 24 25 30
2023/2024921 58 58 40 50 243 106 20 18 17 49 89 173
2024/20253.003 40 50 30 103 381 349 445 294 368 460 242 241
2025/202612.686 569 784 677 559 936 6.251 1.014 652 460 397 230 157
Totale 20.391